arrow
B

Bożena Katarzyna Budziszewska

hematology
H指数:9
被引数:228

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Comparison of Outcomes in Patients with Secondary Acute Promyelocytic Leukemia (APL) and De Novo APL—A Case-Matched Retrospective Analysis of the Polish Adult Leukemia Group (PALG)

比较继发性急性早幼粒细胞白血病(APL)与原发APL患者的结局——波兰成人白血病组(PALG)的病例匹配回顾性分析

Cancers
IF4.4
2026-09-080
OA
Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy – a multicenter study from Polish Adult Leukemia Group

综合老年评估(CGA)量表无法有效识别适合接受强化诱导化疗的老年AML患者——波兰成人白血病小组的多中心研究

2026-02-140
OAAI
Standard Non-Intensive Chemotherapy Vs Venetoclax-Azacytidine (Ven-AZA) for Unfit AML Patients with Therapy-Related Acute Myeloid Leukaemia (t-AML)- a Retrospective Study of Polish Adult Leukemia Group (PALG)

标准非强化化疗与Venetoclax-Azacytidine(Ven-AZA)治疗不适合化疗的伴治疗相关急性髓系白血病(t-AML)患者的比较——一项波兰成人白血病组(PALG)的回顾性研究

BLOOD
IF23.1
2024-11-050
PRE
No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine-a prospective multicenter study by the Polish Adult Leukemia Group
2024-06-130
OAAI
A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience
2024-05-210
OAAI
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group

venetoclax加利妥昔单抗在复发性或难治性慢性淋巴细胞白血病患者中的临床疗效和耐受性-波兰成人白血病研究组的真实世界分析

2023-07-016
OAAI
Persistent imbalance, anti-apoptotic, and anti-inflammatory signature of circulating C-C chemokines and cytokines in patients with paroxysmal nocturnal hemoglobinuria
2022-02-010
PRE
Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia Group

非典型慢性粒细胞白血病: 一例孤儿病-波兰成人白血病小组的多中心报告

2018-03-077
PREAI
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial
2017-02-1324
OAAI